Fangzhou (6086 HK)

Analysis

Consumer Staples • China

Fangzhou is China's leading AI-driven online chronic disease management platform, offering comprehensive medical services, online retail pharmacy services, and customized content and marketing solutions. These services include online consultations, e-prescriptions, pharmaceutical product sales, and AI-powered health management tools. The company was founded in 2015 and is headquartered in Guangzhou, China.

Refresh

Exchange Announcement • 27 Sep 2026 19:15

Adoption Of Share Incentive Scheme

Exchange Announcement • 24 Sep 2026 20:52

2026 Interim Report

Exchange Announcement • 27 Aug 2026 22:27

Interim Results Announcement For The Six Months Ended June 30, 2026

Exchange Announcement • 17 Aug 2026 18:17

Date Of Board Meeting

Exchange Announcement • 17 Jun 2026 22:20

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Adoption Of Share Incentive Scheme

2026 Interim Report

Interim Results Announcement For The Six Months Ended June 30, 2026

Date Of Board Meeting

Amended And Restated Articles Of Association